Neurocrine Biosciences Inc (NBIX) SEC filings
NBIXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 20/3012% below fair value
$167.40−2.00 (-1.18%)
Close on Nov 13, 2026Market cap $17.02BP/E 24.8Yield –
SEC filings
40 of Neurocrine Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 2, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2026 | Nov 2, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 15, 2026 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 5, 2026 | Apr 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 21, 2025 | Nov 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2025 | Oct 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | May 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 21, 2025 | May 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 9, 2025 | Apr 9, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2025 | Apr 4, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 24, 2025 | Jan 27, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 20, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Nov 1, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 11, 2024 | Oct 11, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2024 | Aug 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 28, 2024 | SEC EDGAR |
| Current report | 8-K | May 22, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 1, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 1, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 22, 2024 | Apr 10, 2024 | SEC EDGAR |
See a number that looks wrong?